Respiri Limited develops and commercializes medical devices. The Company offers wheeze detection devices, inhalers, acoustic sensors, and electronic asthma diaries. as well as renders smartphone applications to detect and measure wheezing and coughing problems. Respiri serves customers worldwide.

Change of Company Name and ASX Ticker

Results of Extraordinary General Meeting

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Respiri Ltd (RSH AU)

Change of Company Name and ASX Ticker

Results of Extraordinary General Meeting

RSH Provides Update on Supply Chain and US Tariffs

2025 EGM - Letter to Shareholders & Proxy Form

Notice of Extraordinary General Meeting/Proxy Form

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)